Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
04.09. | Zero Candida Technologies Inc: Zero Candida has Q2 operating loss of $310,000 | 1 | Stockwatch | ||
ZERO CANDIDA TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
03.09. | ZERO CANDIDA LTD: Zero Candida Technologies Reports Financial Results for Three and Six Months Ended June 30, 2025 and Provides Business Update | 156 | PR Newswire | VANCOUVER, BC, Sept. 3, 2025 /PRNewswire/ -- Zero Candida Technologies, Inc. (TSXV: ZCT) (OTCQB: ZCTFF) (FSE: 9L2) (the "Company" or "ZCT"), a Femtech company developing a SMART, AI-driven... ► Artikel lesen | |
05.08. | Zero Candida Technologies Inc: Zero Candida's shares receive DTC eligibility | 1 | Stockwatch | ||
25.07. | Zero Candida Technologies Inc: Zero Candida grants options to buy 560,000 shares | 2 | Stockwatch | ||
16.05. | Zero Candida Technologies Inc: Zero Candida appoints Kostioutchenko as director | 1 | Stockwatch | ||
02.04. | Zero Candida Technologies reports FY results | 1 | Seeking Alpha | ||
02.04. | Zero Candida Technologies Reports Full Year 2024 Financial Results and Business Highlights | 222 | PR Newswire | VANCOUVER, BC, April 2, 2025 /PRNewswire/ -- Zero Candida Technologies, Inc. (TSXV: ZCT) (OTCQB: ZCTFF) (FSE: 9L2) (the "Company" or "ZCT"), a FemTech medical device company revolutionizing... ► Artikel lesen | |
12.03. | Zero Candida Commences Trading on OTCQB Market | 356 | PR Newswire | VANCOUVER, BC, March 12, 2025 /PRNewswire/ -- Zero Candida Technologies, Inc. (TSXV: ZCT) (OTCQB: ZCTFF) (FSE: 9L2) (the "Company" or "ZCT"), a FemTech medical device company revolutionizing... ► Artikel lesen | |
03.02. | Moore Market analysis: Zero Candida potential market will reach over $2 Billion by 2030 | 242 | PR Newswire | According to the report: up to 75% of women will have at least one vaginal yeast infection in their life
VANCOUVER, BC, Feb. 3, 2025 /PRNewswire/ -- A market analysis made by Moore... ► Artikel lesen | |
16.01. | Zero Candida Announces Successful Listing on Frankfurt Stock Exchange and Details of Investor Webinar | 459 | PR Newswire | VANCOUVER, BC, Jan. 16, 2025 /PRNewswire/ -- Zero Candida Technologies, Inc. (TSXV: ZCT) (FSE: 9L2) (the "Company" or "ZCT"), an Israeli FemTech medical device company focused on revolutionizing... ► Artikel lesen | |
06.01. | Zero Candida Announces Plans to Complete Preclinical Studies for FDA Submission by Q3 2025 | 363 | PR Newswire | VANCOUVER, BC, Jan. 6, 2025 /PRNewswire/ -- Zero Candida Technologies, Inc. (TSXV: ZCT), (FSE: 9L2) (the "Company" or "ZCT"), an Israeli FemTech medical device company focused on revolutionizing... ► Artikel lesen | |
16.12.24 | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 16.12.2024 | 906 | Xetra Newsboard | The following instruments on XETRA do have their first trading 16.12.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 16.12.2024
Aktien
1 CA74767K1030 Quantum eMotion Corp.
2... ► Artikel lesen | |
09.12.24 | Zero Candida Receives South African Patent for its ZC- 01 device | 319 | PR Newswire |
Announces IP plans to obtain a worldwide patent portfolio in 2025
VANCOUVER, BC, Dec. 9, 2024 /PRNewswire/ -- Zero Candida (the "Company" or "ZC") (TSXV: ZCT), an Israeli FemTech medical... ► Artikel lesen | |
25.11.24 | Toronto Stock Exchange: Zero Candida Technologies Inc. (ZCT) Opens the Market | 604 | Newsfile | Toronto, Ontario--(Newsfile Corp. - November 25, 2024) - Eli Ben-Haroosh, Co-Founder and Chief Executive Officer, Zero Candida Technologies Inc. (TSXV: ZCT) ("Zero Candida" or the "Company"), joined... ► Artikel lesen | |
25.11.24 | Zero Candida Announces Full Transaction and Being Trading November 25th on the TSX Venture Exchange (Canada) | 500 | PR Newswire | VANCOUVER, BC, Nov. 25, 2024 /PRNewswire/ -- Zero Candida (the "Company" or "ZCT"), (TSXV: ZCT) an Israeli FemTech medical device start-up, is pleased to announce full Transaction and Being... ► Artikel lesen | |
21.11.24 | Zero Candida Announces TSX Venture Exchange Listing Date | 568 | PR Newswire | VANCOUVER, BC, Nov. 21, 2024 /PRNewswire/ -- Zero Candida Technologies Inc. (the "Company" or "Zero Candida") (TSXV: ZCT), a technology company focused on development and commercial exploitation... ► Artikel lesen | |
18.11.24 | Zero Candida Applies to List its Shares on the TSX Venture Exchange | 292 | PR Newswire | VANCOUVER, BC, Nov. 18, 2024 /PRNewswire/ -- Zero Candida Technologies Inc. (the "Company" or "Zero Candida") (TSXV: ZCT), a technology company focused on development and commercial exploitation... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SIEMENS HEALTHINEERS | 48,290 | +0,02 % | Siemens Healthineers: Die Langeweile setzt sich fort! | ||
FRESENIUS | 46,950 | -0,66 % | Fresenius platziert Anleihen im Volumen von 1 Milliarde Euro | DJ Fresenius platziert Anleihen im Volumen von 1 Milliarde Euro
DOW JONES--Fresenius hat nach fast zweijähriger Abwesenheit vom Euro-Anleihemarkt zwei Anleihen im Gesamtvolumen von 1 Milliarde... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 42,450 | +0,17 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
BRIGHTSPRING HEALTH SERVICES | 28,060 | 0,00 % | BrightSpring Health: UBS bestätigt Kaufempfehlung angesichts starker Wachstumsaussichten | ||
ALIGNMENT HEALTHCARE | 16,415 | 0,00 % | Alignment Healthcare, Inc. - 8-K, Current Report | ||
ADAPTHEALTH | 9,160 | 0,00 % | AdaptHealth Corp. - 10-Q, Quarterly Report | ||
LIFESTANCE HEALTH GROUP | 5,170 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Second Quarter 2025 Results | SCOTTSDALE, Ariz., Aug. 07, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
CARL ZEISS MEDITEC | 42,700 | -0,61 % | Carl Zeiss Meditec, HelloFresh, Hensoldt, Lanxess, SMA Solar, Suss MicroTec - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 37,500 | 0,00 % | PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance | SAN JOSE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
UNITEDHEALTH | 295,60 | -0,32 % | Opening Bell: Robinhood, AppLovin, Enphase Energy, Tesla, UnitedHealth, Echostar, Lululemon, Oracle | Der marktbreite S&P 500 kletterte zwar im frühen Handel auf ein Rekordhoch von 6.532 Punkten, drehte danach jedoch ins Minus und schloss 0,32 Prozent tiefer bei 6.481 Zählern. Auch der Dow Jones konnte... ► Artikel lesen | |
GERRESHEIMER | 42,140 | +0,33 % | Aixtron, BayWa, Gerresheimer, HelloFresh, Redcare Pharmacy, Zalando - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
CUPRINA HOLDINGS | 1,650 | 0,00 % | Cuprina Holdings (Cayman) LTD: Cuprina Secures Exclusive Rights to Southeast Asia's First UNIDO/GEF- Demonstrated Medical Waste Recycling Technology | ||
GENEDX | 123,44 | 0,00 % | GeneDx stellt auf Wells Fargo Konferenz strategische Vision für Diagnostik vor | ||
CERIBELL | 11,440 | -3,46 % | Ceribell Files Complaints Against Natus Medical Incorporated with the U.S. International Trade Commission and Federal Court in Delaware | SUNNYVALE, Calif., July 07, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a leading medical technology company transforming the diagnosis and management of patients with serious... ► Artikel lesen | |
ECKERT & ZIEGLER | 16,960 | -1,22 % | BERENBERG stuft ECKERT & ZIEGLER auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat die Bewertung der Aktien von Eckert & Ziegler beim Kursziel von 24 Euro mit "Buy" aufgenommen. Der Medizin- und Messtechnikzulieferer sei der... ► Artikel lesen |